You are here: Industry Insights > Merck

News List

Allergopharma opens new biopharmaceutical production in Reinbek cphi-online
March 06, 2017
Merck's €42 million investment expands the allergies business on a global scale.
Merck launches integrity test system for verification of filters and processing equipment cphi-online
March 01, 2017
Merck's new Integritest 5 instrument is an easy-to-use, portable and fully automated integrity test system for verification of filters and processing equipment.
Merck’s Letermovir, an Investigational Antiviral Medicine for Prevention of Cytomegalovirus (CMV) In firstwordpharma
February 27, 2017
Letermovir Prophylaxis Associated with Lower All-Cause Mortality Through Week 24 Post-Transplant. Company Plans to Submit New Drug Applications for Letermovir in U.S. and EU in 2017.
Merck plans India bio-production plant firstwordpharma
February 21, 2017
Merck KGaA may set up a bio-production plant in India to help local companies create biotechnology drugs and biosimilars, reported livemint.com.
Merck Launches ILÚM Health Solutions americanpharmaceuticalreview
February 20, 2017
Merck, known as MSD outside the United States and Canada, has announced the launch of ILÚM Health Solutions, which provides enterprise-wide disease management tools and services to enable improved outcomes for patients with infectious diseases,
Cladribine tablets significantly reduced brain atrophy in patients with multiple sclerosis worldpharmanews
February 10, 2017
Merck, a leading science and technology company, today announced the publication of the results of a post hoc analysis of the Phase III CLARITY study in Multiple Sclerosis Journal.
Merck’s ‘Parents of Fertility’ initiative supported by Farah Khan expressbpd
February 09, 2017
Launches a video sharing her journey to parenthood with IVF to encourage couples who are unable to conceive to seek specialised treatment
Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results americanpharmaceuticalreview
February 06, 2017
Merck, known as MSD outside the United States and Canada, has announced financial results for the fourth quarter and full year of 2016.
BMS receives $625 million patent settlement boost from Merck pharmafile
January 24, 2017
Bristol-Myers Squibb were in desperate need of releasing good news after the brief announcement that it would no longer be pursuing an accelerated regulatory pathway for Opdivo with Yervoy...
Merck announces settlement and license agreement resolving KEYTRUDA financialexpress
January 24, 2017
The company will make a one-time payment of $625 million to Bristol-Myers Squibb and provide royalties on the worldwide sales of KEYTRUDA

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page